×
About 1,132 results

ALLMedicine Oropharyngeal Cancer Center

Research & Reviews  551 results

Identification of novel methylation markers in HPV-associated oropharyngeal cancer: gen...
https://doi.org/10.1038/s41388-020-1327-z
Oncogene Misawa K, Imai A et. al.

May 14th, 2020 - Human papilloma virus (HPV)-associated oropharyngeal cancer (OPC) is an independent tumour type with regard to cellular, biological, and clinical features. The use of non-invasive biomarkers such as circulating tumour DNA (ctDNA) may be relevant i...

Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Rev...
https://doi.org/10.1001/jamaoto.2019.4811
JAMA Otolaryngology-- Head & Neck Surgery; Day AT, Fakhry C et. al.

May 6th, 2020 - The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer (OPC) is anticipated to rise over the next few decades until the effects of prophylactic vaccination are realized, which highlights the potential importance of secondary pre...

Palatine Tonsilloliths and Actinomyces: A Multi-institutional Study of Adult Patients U...
https://doi.org/10.1177/0194599820921392
Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery; Arvisais-Anhalt S, Quinn A et. al.

May 4th, 2020 - To better characterize associations between Actinomyces and tonsillolith versus nontonsillolith tonsillectomy specimens. Bi-institutional retrospective case-case study. University and county hospital. Adult patients with a clinical history of tons...

HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV dr...
https://doi.org/10.1016/j.oraloncology.2020.104721
Oral Oncology; Schroeder L, Pring M et. al.

May 3rd, 2020 - To compare risk factors and survival in people with oropharyngeal cancer (OPC) and cancer unknown primary (CUP). We recruited 5511 people with head and neck cancer between 2011 and 2014. We collected data on age, gender, smoking, sexual behaviour,...

Prospective longitudinal patient-reported outcomes of swallowing following intensity mo...
https://doi.org/10.1016/j.radonc.2020.04.021
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology; Grant SR, Hutcheson KA et. al.

May 3rd, 2020 - With an enlarging population of long-term oropharyngeal cancer survivors, dysphagia is an increasingly important toxicity following oropharynx cancer treatment. While lower doses to normal surrounding structures may be achieved with intensity modu...

see more →

Clinicaltrials.gov  569 results

Identification of novel methylation markers in HPV-associated oropharyngeal cancer: gen...
https://doi.org/10.1038/s41388-020-1327-z
Oncogene Misawa K, Imai A et. al.

May 14th, 2020 - Human papilloma virus (HPV)-associated oropharyngeal cancer (OPC) is an independent tumour type with regard to cellular, biological, and clinical features. The use of non-invasive biomarkers such as circulating tumour DNA (ctDNA) may be relevant i...

Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Rev...
https://doi.org/10.1001/jamaoto.2019.4811
JAMA Otolaryngology-- Head & Neck Surgery; Day AT, Fakhry C et. al.

May 6th, 2020 - The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer (OPC) is anticipated to rise over the next few decades until the effects of prophylactic vaccination are realized, which highlights the potential importance of secondary pre...

Palatine Tonsilloliths and Actinomyces: A Multi-institutional Study of Adult Patients U...
https://doi.org/10.1177/0194599820921392
Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery; Arvisais-Anhalt S, Quinn A et. al.

May 4th, 2020 - To better characterize associations between Actinomyces and tonsillolith versus nontonsillolith tonsillectomy specimens. Bi-institutional retrospective case-case study. University and county hospital. Adult patients with a clinical history of tons...

HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV dr...
https://doi.org/10.1016/j.oraloncology.2020.104721
Oral Oncology; Schroeder L, Pring M et. al.

May 3rd, 2020 - To compare risk factors and survival in people with oropharyngeal cancer (OPC) and cancer unknown primary (CUP). We recruited 5511 people with head and neck cancer between 2011 and 2014. We collected data on age, gender, smoking, sexual behaviour,...

Prospective longitudinal patient-reported outcomes of swallowing following intensity mo...
https://doi.org/10.1016/j.radonc.2020.04.021
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology; Grant SR, Hutcheson KA et. al.

May 3rd, 2020 - With an enlarging population of long-term oropharyngeal cancer survivors, dysphagia is an increasingly important toxicity following oropharynx cancer treatment. While lower doses to normal surrounding structures may be achieved with intensity modu...

see more →

News  11 results

ASCO: Deintensified treatment in p16+ oropharyngeal cancer needs evaluation
https://www.mdedge.com/hematology-oncology/article/200108/head-neck-cancers/asco-deintensified-treatment-p16-oropharyngeal?channel=39313
Caleb Rans

May 2nd, 2019 - Treatment deintensification for patients with p16+ oropharyngeal cancer (OPC) should occur only in the context of a clinical trial, according to a provisional clinical opinion released by the American Society of Clinical Oncology (ASCO). “The hypo.

HPV16 Vaccine Yields Added Benefit in Recurrent Throat Cancer
https://www.medpagetoday.com/hematologyoncology/othercancers/75474

Oct 3rd, 2018 - NEW YORK CITY -- Adding a tumor-specific vaccine to PD-1 checkpoint inhibition was safe and effective in HPV16-positive patients with recurrent or metastatic oropharyngeal cancer, a small phase II trial found. Among 24 patients treated with nivolu...

Risk for HPV-Related Throat Cancer Is 'Reassuringly' Low
https://www.medscape.com/viewarticle/887728

Oct 26th, 2017 - The risk of developing oropharyngeal cancer (OPC) related to oral human papillomavirus (HPV) infection is very low in the general population and even in people with specific behavioral risk factors, a new study suggests. "Oropharyngeal cancer has ...

Oral Sex, Smoking Increase Men's HPV Risk
https://www.medpagetoday.com/infectiousdisease/stds/68723

Oct 23rd, 2017 - Action Points Men who smoked and had five or more lifetime oral sex partners had the highest prevalence of oral oncogenic human papilloma virus (HPV) infection (14.9%). The study suggests that even though the prevalence of infection is higher in m...

Novel Approach Reduces Treatment Toxicities in Patients With HPV-Related Oropharyngeal Cancer
https://www.onclive.com/publications/oncology-live/2017/vol-19-no-19/novel-approach-reduces-treatment-toxicities-in-patients-with-hpvrelated-oropharyngeal-cancer

Oct 4th, 2017 - Paul Dent, PhD   Surgeon Chief of Head and Neck Service Andrew S. Poklepovic, MD   Radiation Oncologist Vice Chair, Department of Radiation Oncology, Experimental Therapeutics The incidence of mouth and throat cancer is on the rise due to transmis...

see more →

Patient Education  1 results see all →